Andere talen AFT Pharmaceuticals Limited

Aandelen

AFT

NZAFTE0001S4

slotkoers New Zealand S.E. Andere beurzen 00:00:00 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3 ^NZD	0,00%		-2,91%	-14,29%

01/05	AFT Pharmaceuticals tekent licentieovereenkomst in Brazilië voor Maxigesic IV	MT
24/04	Nieuw-Zeelandse aandelen stijgen na Amerikaanse winstrally; AFT Pharmaceuticals gaat plaatselijke littekenbehandeling ontwikkelen	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV	01/05
New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment	24/04
AFT Pharmaceuticals, Massey Ventures, Gillies McIndoe Research Institute Partner to Develop Topical Scar Treatment	24/04
AFT Pharmaceuticals Limited, Massey Ventures, Gilles Mcindoe Research Institute to Develop Scar Treatment	23/04
New Zealand Shares Close Flat on Monday; Fletcher Building Chair Steps Down	04/03
AFT Pharmaceuticals to Expand Global Footprint with Signing of Supply, Production Deals	04/03
Aft Expands Its Co-Operation with Hikma Pharmaceuticals	03/03
New Zealand Shares Rebound on Friday Close; AFT Pharmaceuticals Raises Operation Profit Guidance	16/02
AFT Pharmaceuticals Boosts Operating Profit Guidance for Fiscal Year 2024	16/02
AFT Pharmaceuticals Limited Updates Earnings Guidance for the Fiscal Year 2024	15/02
AFT Pharmaceuticals' Licensee Launches Pain Relief Medication in US; Shares Rise 4%	07/02
AFT Pharmaceuticals’ Maxigesic IV Launches in the US	06/02
AFT Pharmaceuticals Ties Up with Belgian Firm to Develop Skin Medication	19/01
Hyloris Pharmaceuticals SA Enters into Partnership with AFT Pharmaceuticals to Develop a Novel Mucoadhesive Film for the Treatment of Vulvar Lichen Sclerosus	18/01
AFT Pharmaceuticals Ties Up with Hyloris to Develop Burning Mouth Syndrome Treatment Candidate	22/12
AFT Pharmaceuticals Limited Enters into Partnership with Hyloris Pharmaceuticals	21/12
France keeps 2024 bond issuance steady at 285 bln euros	13/12
AFT Pharmaceuticals Limited Reaffirms Earnings Guidance for the Fiscal Year 2024	22/11
AFT Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2023	22/11
AFT Pharmaceuticals Secures Clearance to Sell Antiseptic Ointment in China	21/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen AFT Pharmaceuticals Limited

Aandelen

AFT

NZAFTE0001S4

Andere talen

Filters